Xanthium strumarium L. (Asteraceae) is traditionally used in Korea to treat skin diseases. In this study, we investigated the effects of a X. strumarium stem extract on melanin synthesis. It inhibited melanin synthesis in a concentration-dependent manner, but it did not directly inhibit tyrosinase, the rate-limiting melanogenic enzyme, and instead downregulated microphthalmia-associated transcription factor (MITF) and tyrosinase expression. MITF, the master regulator of pigmentation, is a target of the Wnt signaling pathway, which includes glycogen synthase kinase 3 (GSK3) and -catenin. Hence, the influence of X. strumarium stem extract on GSK3 and -catenin was further investigated. X. strumarium induced GSK3 phosphorylation (inactivation), but the level of -catenin did not change. Moreover, a specific GSK3 inhibitor restored X. strumarium-induced melanin reduction. Hence, we suggest that X. strumarium inhibits melanin synthesis through downregulation of tyrosinase via GSK3 phosphorylation.
Recently, the use of medicinal herbs as skin-whitening agents has been under examination. Xanthium strumarium L. is readily found growing on the streets and in the fields in Korea, Northeast Asia, and Europe. [1] [2] [3] It is effective in treating fevers, skin disease, pain, neuralgia, and malignant tumors. 4) It contains carboxyatractyloside, xanthatin, xanthinosin, xanthanol, isoxanthanol, alkaloids, caffeyolquinic acids, and thiazinedione. 5, 6) These components have been reported to have curative effects on skin diseases, including eczema, 7, 8) atopic dermatitis, 9) and inflammation. 10) In the present study, we investigated to determine whether X. strumarium has any such effects on melanogenesis.
Melanocytes are epidermal pigment cells in which melanin pigments are produced. In mammals, melanin synthesis is stimulated by ultraviolet B radiation, -melanocyte-stimulating hormone, endothelin 1, and a wide variety of growth factors and cytokines. 11) Increased levels of cAMP and the activation of protein kinase A promote increases in the expression of microphthalmiaassociated transcription factor (MITF). 12) MITF is a key regulator in melanocyte development and melanogenesis, because it is a critical transcription regulator in the expression of three major melanogenic enzymes: tyrosinase, tyrosinase-related protein 1 (TRP1), and TRP2. 13) Signaling pathways, such as the extracellular signalregulated kinase (ERK) and Akt pathways, regulate melanogenesis. [14] [15] [16] [17] The Wnt signaling pathway is also involved in MITF expression. Activation of the Wnt pathway leads to glycogen synthase kinase 3 (GSK3) inactivation (phosphorylation) and -catenin accumulation. 18) MITF expression is increased by accumulated -catenin, which contributes to melanogenesis. 19) Therefore, GSK3 inhibition should promote melanogenesis. In contrast, activated GSK3 induces the phosphorylation of -catenin, which leads to the ubiquitination and degradation of -catenin. 20) In the present study, we found that a X. strumarium extract inhibited melanogenesis by decreasing the expression of MITF, but it had no influence on the ERK or the Akt pathway. Hence, we attempted to determine the effects of X. strumarium extract on the mechanisms regulating hypopigmentation.
Materials and Methods
, and mushroom tyrosinase were purchased from Sigma-Aldrich (St. Louis, MO). Antibodies specific for phospho-ERK1/2 (Thr202/Tyr204, #9101S), phosphor-Akt (Ser473, #9271), phospho-GSK3 (#9336), andcatenin (#9581) were from Cell Signaling Technology (Beverly, MA). Antibodies specific for tyrosinase (C-19) and actin (I-19) were from Santa Cruz Biotechnology (Santa Cruz, CA). Microphthalmia Ab-1 (C5, MS-771-P0) was from NeoMarkers (Fremont, CA). Secondary antibodies specific for anti-goat IgG (PI-9500), anti-mouse IgG (PI-2000), and anti-rabbit IgG (PI-1000) were from Vector Laboratories (Burlingame, CA).
Preparation of X. strumarium extract. X. strumarium was collected from the hills of Goesan-gun, Chungcheongbuk-do, Korea in July * These authors contributed equally to this work.
y To whom correspondence should be addressed. Tel/Fax: +82-2-820-5768; E-mail: ds kim@cau.ac.kr Abbreviations: BIO, (2 0 Z,3 0 E)-6-bromoindirubin-3 0 -oxime; DOPA, 3,4-dihydroxyphenylalanine; ERK, extracellular signal-regulated kinase; GSK3, glycogen synthase kinase 3; MITF, microphthalmia-associated transcription factor; TRP, tyrosinase-related protein Biosci. Biotechnol. Biochem., 76 (4), [767] [768] [769] [770] [771] 2012 2010. Stems of X. strumarium were dried in a TFD series freeze dryer (ilshinBioBase, Dae-jeon, Korea) for 2 d. The stems were crushed and then extracted in 7 L of 80% methanol (L260-18; SK Chemicals, Ul-san, Korea) for 2 weeks. Then they were filtered with filter paper through a funnel and concentrated in a vacuum rotary evaporator (EYELA, Tokyo).
Cell cultures. The Mel-Ab cell line is a mouse-derived spontaneously immortalized melanocyte line that produces large amounts of melanin. 21) Mel-Ab cells were incubated in DMEM supplemented with 10% v/v fetal bovine serum (FBS; Hyclone, Logan, UT), 100 nM TPA, 1 nM CT, 50 mg/mL of streptomycin, and 50 mg/mL of penicillin (Hyclone) at 37 C under 5% CO 2 .
Cell viability assay. Cell viability was determined by crystal violet assay. Cells (5 Â 10 4 cells/well) were seeded into 24-well plates. After incubation of cells with various concentrations (1-50 mg/mL) of X. strumarium extract for 24 h and 72 h, the media were removed and the cells were stained with 0.1% crystal violet in 10% ethanol for 5 min at room temperature. The cells were then rinsed 4 times with distilled water, and the crystal violet retained by adhered cells was extracted with 95% ethanol. Absorbance was determined at 590 nm with a VERSAMax ELISA reader (Molecular Devices, Sunnyvale, CA).
Measurement of melanin content, and microscopy. Melanin content was measured as previously described, with slight modifications. 22) Cells (2 Â 10 5 cells/well), seeded into six-well plates for 24 h, were treated with various concentrations (1-50 mg/mL) of X. strumarium extract in DMEM containing 10% FBS over 3 d. The cell pellets were dissolved in 550 mL of 1 N NaOH at 100 C for 30 min, and centrifuged at 15,000 rpm for 5 min. Supernatants were analyzed at 400 nm with an ELISA reader. Before the melanin content was measured, the cells were observed using a model IX50 phase contrast microscope (Olympus, Tokyo) and photographed using a DCM300 digital camera designed for the microscope (Scopetek, Hangzhou, China), supported by ScopePhoto software (Scopetek).
Tyrosinase activity. Tyrosinase activity was assayed as DOPA oxidase activity. Aliquots containing 2 Â 10 5 Mel-Ab cells were incubated in 6-well plates with various concentrations (1-50 mg/mL) of X. strumarium extract in DMEM for 3 d. They were washed with phosphate buffered saline and lysed with lysis buffer (0.1 M phosphate buffer pH 6.8 containing 1% Triton X-100). Then they were disrupted by freeze-thawing, and the lysates were clarified by centrifugation at 15,000 rpm for 30 min. After quantification of the protein content with a protein assay kit (Bio-Rad, Hercules, CA), the protein concentrations were adjusted with lysis buffer. Then 90 mL of each lysate was pipetted into the wells of a 96-well plate, and 10 mL of 10 mM L-DOPA was added. Control wells contained 90 mL of lysis buffer and 10 mL of 10 mM L-DOPA. After incubation at 37 C for 20 min, dopachrome formation was monitored by measuring the absorbance at 475 nm using an ELISA reader. A cell-free assay system was used to determine the direct effect of X. strumarium extract on tyrosinase activity. Phosphate buffer (70 mL) containing X. strumarium extract was mixed with 20 mL (53.7 units/mL) of mushroom tyrosinase, and 10 mL of 10 mM L-DOPA was added. Following incubation at 37 C for 20 min, the absorbance was measured at 475 nm.
Western blot analysis. Cells were lysed in cell lysis buffer, 62.5 mM Tris-HCl pH 6.8, 2% sodium dodecyl sulfate (SDS), 5% -mercaptoethanol, 2 mM phenylmethylsulfonyl fluoride, protease inhibitors (CompleteÔ; Roche, Mannheim, Germany), 1 mM Na 3 VO 4 , 50 mM NaF, and 10 mM EDTA. Proteins (20 mg per lane) were separated by SDS-polyacrylamide gel electrophoresis and blotted onto polyvinylidene fluoride (PVDF) membranes, which were then saturated with 5% dried milk in Tris-buffered saline containing 0.5% Tween 20. Blots were then incubated with the appropriate primary antibodies at a dilution of 1:1,000, and further incubated with horseradish peroxidaseconjugated secondary antibody. Bound antibodies were detected using an Enhanced Chemiluminescence Plus Kit (Amersham International, Little Chalfont, UK). Images of the blotted membranes were obtained using a LAS-1000 Lumino-Image analyzer (Fuji Film, Tokyo).
Statistics.
Differences between results were assessed for significance by Student's t-test. p values of <0.05 were regarded as significant.
Results
Effects of X. strumarium extract on cell viability Mel-Ab cells were treated with extracts (0-100 mg/ mL) of X. strumarium to determine whether X. strumarium would have a cytotoxic effect. Cell viability was determined by crystal violet assay. The X. strumarium extract showed no cytotoxic effect on the Mel-Ab cells at concentrations of 50 mM (Fig. 1). X. strumarium extract inhibited tyrosinase activity and melanin synthesis
To investigate the hypopigmentary effect of X. strumarium extract, melanin content and tyrosinase activity assays were performed on Mel-Ab cells. The cells were exposed to extracts (0-50 mg/mL) of X. strumarium for 3 d and then photographed using a phase contrast microscope ( Fig. 2A) . X. strumarium extract significantly decreased melanin synthesis, in a concentrationdependent manner (Fig. 2B) . Moreover, treatment with X. strumarium extract significantly reduced tyrosinase activity (Fig. 2C) . Additionally, it was determined whether X. strumarium extract would have a direct effect on tyrosinase activity using mushroom tyrosinase. The X. strumarium extract showed no direct inhibitory effect on tyrosinase activity (Fig. 2D) . Based on these After serum starvation for 24 h, cells were incubated in serum-free media with various concentrations (1-100 mg/mL) of X. strumarium extract for 24 h (A) and 72 h (B). The viability of the cells was determined by crystal violet assay. Each measurement was made in triplicate, and data represent the mean AE SD.
results, we suggest that the hypopigmentary effect of X. strumarium extract is due to inhibition of tyrosinase expression, and not to direct inhibition of tyrosinase.
Effects of X. strumarium extract on MITF and tyrosinase protein levels
Tyrosinase expression is tightly regulated through the activation of MITF production. Hence, we examined the effects of X. strumarium extract on the production of MITF and tyrosinase in a time-course experiment. In conformity with decreased melanogenesis after X. strumarium treatment (Fig. 3A) , the X. strumarium extract inhibited the production of both MITF and its downstream molecule, tyrosinase, in a time-dependent manner (Fig. 3B) .
Effects of X. strumarium extract on GSK3 phosphorylation and melanogenesis
The ERK and Akt pathways regulate melanogenesis. Hence, we investigated to determine whether ERK and/ or Akt would be affected by the X. strumarium extract in a time-course experiment. The extract showed no influence on ERK or Akt phosphorylation (Fig. 4) . In contrast, GSK3 phosphorylation (inactivation) occurred after 3-6 h of treatment with X. strumarium extract (Fig. 4) . However, the -catenin level was not changed A, Mel-Ab cells were cultured with 1-50 mg/mL X. strumarium extract for 3 d, and phase-contrast pictures were obtained with a digital camera designed for the microscope. B, Melanin contents were measured. C, The tyrosinase activity of the X. strumarium-treated cells was measured. D, To test the direct effect on tyrosinase, tyrosinase activity was measured in a cell-free system. Arbutin (100 mg/mL) was used as positive control. Each determination was made in triplicate, and the data shown represent mean AE SD.
Ã p < 0:05, ÃÃ p < 0:01 as compared to control. Mel-Ab cells were cultured with 50 mg/mL of X. strumarium extract for 24-72 h. A, Phase-contrast photographs were obtained with a microscope-mounted digital camera. B, Whole-cell lysates were subjected to Western blot analysis with antibodies against MITF and tyrosinase. Equal protein loading was checked by reaction with actin.
by treatment with the X. strumarium extract at 0-6 h. Because MITF is a target of the Wnt pathway, we checked for the involvement of GSK3 phosphorylation using BIO, a specific GSK3 inhibitor. Cells were treated with the X. strumarium extract for 3 d in the presence and the absence of BIO. BIO abrogated X. strumarium-induced melanin reduction (Fig. 5A ) and inhibited GSK3 phosphorylation in X. strumariumtreated cells (Fig. 5B) . These data are consistent with the hypothesis that GSK3 phosphorylation is related to the reduction of melanogenesis by X. strumarium extract.
Discussion
Although X. strumarium is used to treat skin diseases due to its antibacterial and anticancer effects, 23) its effects on melanogenesis are unclear. Accordingly, in the present study, we investigated the hypopigmentary effect and the molecular regulatory properties of the X. strumarium extract. We found that X. strumarium extract downregulated MITF and tyrosinase expression, which strongly suggests that X. strumarium decreases melanogenesis through regulation of MITF and tyrosinase.
As shown in Fig. 2 , melanin contents were decreased by X. strumarium extract in a concentration-dependent manner. Tyrosinase is the rate-limiting enzyme involved in regulation of melanin biosynthesis. 24) However, the X. strumarium extract showed no effect on tyrosinase activity in the cell-free system, although it did inhibit melanin contents, indicating that it had no direct inhibitory effect on tyrosinase. We repeated the experiment with tyrosinase extracted from cultured Mel-Ab cells, and obtained results that were identical to those with mushroom tyrosinase (data not shown). Furthermore, earlier studies using mushroom tyrosinase have suggested a strong correlation of efficacy with experiments using mammalian tyrosinase. 25) This suggests that X. strumarium controls the intracellular signaling pathways and regulates the expression of tyrosinase. Hence, we investigated further the melanogenesis-related signal transduction pathway after X. strumarium treatment.
MITF is known to be deeply involved in melanogenesis. Hence, we examined the effect of the X. strumarium extract on the production of MITF and tyrosinase in Mel-Ab cells. As expected, the X. strumarium extract inhibited the production of both MITF and its downstream enzyme, tyrosinase (Fig. 3B) . Several studies have found evidence for the involvement of the ERK and/or the Akt pathway in the regulation of melanogenesis 14) but the X. strumarium extract did not activate the ERK or the Akt signaling pathways (Fig. 4) . Because X. strumarium extract has multiple components, we did not detect specific signal transduction pathways related to MITF downregulation. Thus the suppression of MITF expression was induced by the combined effects of various X. strumarium components.
In contrast, we found that GSK3 was phosphorylated by X. strumarium. GSK3 has been widely implicated in the regulation of cell homeostasis by its ability to phosphorylate a broad range of substrates, including glycogen synthase, the microtubule-associated protein tau, and -catenin.
26) It has been reported that phosphorylation (inactivation) of GSK3 leads to the accumulation of -catenin 27) but our results indicate that the -catenin level was not changed by treatment with the X. strumarium extract at 0-6 h, although Mel-Ab cells were treated with 50 mg/mL of the X. strumarium extract at the time points indicated. Whole-cell lysates were then subjected to Western blot analysis with antibodies against phosphospecific ERK, phospho-specific Akt, phospho-specific GSK3, and -catenin. Equal protein loading was checked by reaction with actin. Mel-Ab cells were treated with X. strumarium extract for 3 d in the presence and the absence of BIO, a specific GSK3 inhibitor. A, Melanin contents were measured.
ÃÃ p < 0:01 as compared to control. B, Western blot analysis was performed with antibodies against phospho-GSK3. Equal protein loading was checked by reaction with actin.
GSK3 was inactivated. Thus -catenin might not be involved in X. strumarium extract-induced melanin reduction. Hence, we checked further for the possible involvement of GSK3 in melanogenesis using BIO, a specific GSK3 inhibitor. BIO recovered X. strumarium-induced melanin reduction (Fig. 5A) . It has been reported that nonphosphorylated GSK3 phosphorylates MITF on serine 289, thereby enhancing its binding to the tyrosinase promoter. 28) Taking this into consideration, our data indicate that X. strumarium-induced GSK3 phosphorylation decreases the binding activity of MITF to the tyrosinase promoter. We suggest that X. strumarium extract inhibits melanogenesis by decreasing tyrosinase expression levels through GSK3 phosphorylation (Fig. 6) . How X. strumarium extract functions upstream of the GSK3 pathway remains unclear.
In the present study, we identified an extract of X. strumarium as an effective inhibitor of hyperpigmentation. Thus it is possible to develop X. strumarium as a new skin-whitening agent. The X. strumarium extract inhibited melanogenesis by decreasing tyrosinase expression levels through GSK3 phosphorylation.
